Multipronged approaches to develop immunotherapy targeting NETs
Researcher: Xianxin Hua, MD, PhD Location: Perelman School of Medicine, University of Pennsylvania State: Pennsylvania Year: 2018 Status: Active Award: Accelerator Award
Leave it blank
This 4-year study will develop nanobody-directed CAR T-cell therapy with various combinatory approaches in laboratory models to kill NET cells. The research will be carried out in collaboration with Dr. Carl June at the University of Pennsylvania, whose work was integrally involved with the approval of CAR T-cell therapy, a personalized, breakthrough immunotherapy for blood cancer. The multipronged approaches will significantly increase the opportunity to develop efficacious NET-specific immunotherapy.
NET Research Foundation
321 Columbus Avenue, Suite 5R
Boston MA 02116